In clinical trials, the marine algal extracts and compounds reversed the obesity and T2D effects by reducing bodyweight and food intake and improving their plasma biochemical parameters, such as glucose and glucose intolerance, lipoprotein levels, antioxidant defense system and plasma insulin levels. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.